Lucid Diagnostics
LUCD
35 hedge funds and large institutions have $17.8M invested in Lucid Diagnostics in 2021 Q4 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
8.99% more ownership
Funds ownership: 0% → 8.99% (+9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LM
Luminus Management
Houston,
Texas
|
+$10.2M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.53M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.02M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$1.96M |
| 5 |
CC
Covalis Capital
London,
United Kingdom
|
+$1.09M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $16K | +$25.2K | +3,108 | New |
|
27
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
| $15K | +$22.5K | +2,772 | New |
|
|
AIG
28
American International Group
New York
| $14K | +$21.8K | +2,682 | New |
|
29
Citigroup
New York
| $13K | +$19.1K | +2,351 | New |
|
30
UBS Group
Zurich,
Switzerland
| $10K | +$15.3K | +1,888 | New |
|
31
Royal Bank of Canada
Toronto,
Ontario, Canada
| $9K | +$13.6K | +1,674 | New |
|
|
TRCT
32
Tower Research Capital (TRC)
New York
| $6K | +$8.77K | +1,081 | New |
|
33
Legal & General Group
London,
United Kingdom
| $3K | +$4.06K | +500 | New |
|
|
AIP
34
Ameritas Investment Partners
Lincoln,
Nebraska
| $2K | +$3.17K | +390 | New |
|
35
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $1K | +$1.62K | +200 | New |
|
LUCD Hedge Fund Activity: Q4 2021 in Review
35 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q4 2021, worth a combined $17.8M.
Buyers outnumbered sellers: 35 funds opened new LUCD positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Luminus Management, opening a new position worth an estimated $10.2M.
- 35 institutional investors held Lucid Diagnostics (LUCD) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $17.8M of Lucid Diagnostics stock for Q4 2021.
- 35 funds opened new Lucid Diagnostics positions in Q4 2021 and 0 closed out, a net change of +35 holders.
- The largest Lucid Diagnostics buyer in Q4 2021 was Luminus Management, an estimated $10.2M added.
Based on aggregated 13F filings for Q4 2021.